Epidemics

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma

REDWOOD CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company…

1 year ago

Tier-One Canadian Life and Health Insurance Carrier Selects Sapiens Insurance Platform to Foster Innovation, Drive Efficiency, and Improve Agent & Customer Experience

Sapiens Insurance Platform for Life & Annuities will provide one integrated solution to support all products and services throughout the…

1 year ago

Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to…

1 year ago

Better Preparing for Future Pandemics

Over $4 million for cutting-edge infrastructure at INRS LAVAL, QC, Sept. 3, 2024 /CNW/ - As the climate continues to change,…

1 year ago

Regeneron Provides Update on Biologics License Application for Linvoseltamab

TARRYTOWN, N.Y., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and…

1 year ago

NHI Announces Pricing of Upsized Public Offering of Common Stock

MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today the pricing…

1 year ago

NHI Announces Public Offering Of Common Stock

MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today that it…

1 year ago

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

THB335 Phase 1 SAD/MAD clinical trial progressing; study now on track to report clinical results in 1Q’25 Strong financial position…

1 year ago

Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update

Sanofi plans to expand KT-474/SAR444656 (IRAK4) Phase 2 clinical trials in HS and AD to accelerate overall development timelines following…

1 year ago